Mamaearth
PublicMamaearth is now publicly traded
The data on this page reflects Mamaearth's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Nov 7, 2023
Last Round
Angel
Sep 15, 2022
Est. Valuation at Exit
$1.05B
Total Funding Raised
$170.01M
Company Overview
Mamaearth operates in Consumer Goods and is based in Gurugram, Haryana. Its recorded funding history includes an Angel round in September 2022.
Mamaearth is a beauty and personal care company that specializes in creating safe, toxin-free products made from natural ingredients to address consumer needs.
Sector
Consumer Goods
AI Layer
Application
Mamaearth Comparables
Compare Mamaearth with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Daughter Earth | 72% | |
| Be Bodywise | 72% | |
| Re'equil | 71% |
For institutional investors. Book with your work email.
Mamaearth Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Nov 7, 2023 | ||||
| Angel | Sep 15, 2022 | ||||
| Series F | Jan 1, 2022 | ||||
| Series E | Jul 26, 2021 | ||||
| Series D | Jan 8, 2020 | ||||
Series A | Sep 11, 2018 |
For institutional investors. Book with your work email.
Mamaearth Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JM Financial | IPO |
| Stellaris Venture Partners | Series D, Series E, Series A |
| Citigroup Global Markets India | IPO |
| Axis Asset Management Company | IPO |
| Ashoka WhiteOak Capital | IPO |
| Peak XV Partners | Series E, Series D |
| Titan Capital | Series E, Seed |
For institutional investors. Book with your work email.
Mamaearth Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.